{"id":692318,"date":"2022-10-05T08:05:29","date_gmt":"2022-10-05T12:05:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/"},"modified":"2022-10-05T08:05:29","modified_gmt":"2022-10-05T12:05:29","slug":"nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/","title":{"rendered":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SEATTLE, Oct.  05, 2022  (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter 2022 before market open on Tuesday, November 1, 2022.<\/p>\n<p>The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QgU9pnc6vCHRAm7K7-J3JLM4Y2BJXrgXOeq7aAAXiux3GgSIUrB20-QdP6rYj2-yHFS-t2j2mw3UnfUXXd0caQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.nautilus.bio<\/a>.<\/p>\n<p>\n        <strong>About Nautilus Biotechnology, Inc.<\/strong><br \/>\n        <br \/>With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus\u2019 mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QgU9pnc6vCHRAm7K7-J3JNSfT6X9hEx8Ao39MnSygNXHVrKOziS3p73ygAcTLopnLlOH_5AxPYLXb1iaZx6Ikg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.nautilus.bio<\/u><\/a>.<\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>press@nautilus.bio<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>investorrelations@nautilus.bio<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTg4ZDUyNjAtNWZjYS00YmUyLTgzNzktZjZmNzEwNDM4Y2Y0LTEyMTk4NjU=\/tiny\/Nautilus-Biotechnology-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter 2022 before market open on Tuesday, November 1, 2022. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692318","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter 2022 before market open on Tuesday, November 1, 2022. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life &hellip; Continue reading &quot;Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-05T12:05:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022\",\"datePublished\":\"2022-10-05T12:05:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/\"},\"wordCount\":185,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/\",\"name\":\"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\",\"datePublished\":\"2022-10-05T12:05:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/","og_locale":"en_US","og_type":"article","og_title":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk","og_description":"SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) &#8212; Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or \u201cNautilus\u201d), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the third quarter 2022 before market open on Tuesday, November 1, 2022. The company\u2019s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time \/ 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life &hellip; Continue reading \"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-05T12:05:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022","datePublished":"2022-10-05T12:05:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/"},"wordCount":185,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/","name":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=","datePublished":"2022-10-05T12:05:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTEwMyM1MTg3OTM0IzIyMDgzMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nautilus-biotechnology-to-announce-third-quarter-2022-financial-results-on-november-1-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692318"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692318\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}